The Future of Radiology: What Are the Threats and How to Respond to Them

Editorial Staff | | Health Imaging | Policy & Regulations

Nov. 28, 8:30-10:00 a.m. | N227

There are a number of threats facing radiology, both at the individual practice level and beyond. This session preps participants on how to deal with these challenges, including declining reimbursements, reduced procedure volumes and others.

 

Speaker Information:

•             Jonathan W. Berlin, MD, NorthShore University Health, Evanston, Ill.

•             David C. Levin, MD, Thomas Jefferson University, Philadelphia

•             Vijay Madan Rao, MD, Thomas Jefferson University, Philadelphia

Editorial Staff

Related Content

FDA seeking nominations for mammography advisory committee
The biggest obstacles facing radiology business managers in 2025
Policies and regulations shaping radiology in 2025
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers
U.S. moves closer to establishing domestic supply of Mo-99 for nuclear imaging
Pending radiology bills in Congress and predicting the Trump administration's impact on imaging

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.